Back

Influence of pullback pressure gradient on patient-reported and clinical outcomes in coronary artery disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New therapeutic insights into coronary artery disease Intracoronary Flow and Pressure Measurements ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Carlos Collet

New York Presbyterian Hospital Of Columbia And Cornell, New York (United States of America)

4 More presentations in this session

Presentation thumbnail
Combined effects of clonal hematopoiesis of intermediate potential and P2Y12 inhibitors on outcomes of patients with ST-segment elevation myocardial infarction: A prospective study
Doctor R. CHEN (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Clinical observations on the use of the coronary sinus reducer for managing refractory angina pectoris: Insights from a single center case series
Associate Professor L. Desta (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Effect of colchicine on the pericoronary inflammation index of coronary computed tomography angiography: the COPIX Randomized Clinical trial
Ms C. Barbosa (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Vagal nerve stimulation improves myocardial recovery after STEMI: a randomized trial
Doctor A. Stern Bronshtein (Haifa, IL)
Abstract Slides Video

Access the full session

Session thumbnail
New therapeutic insights into coronary artery disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact of the pullback pressure gradient (PPG) on PCI planning and decision-making
thumbnail
Congress Presentation
Association between pre-procedural pathophysiological pattern of coronary disease and immediate hemodynamic outcome post-percutaneous coronary intervention
thumbnail
Congress Presentation
Mechanisms leading to peri-procedural myocardial infarction in patients with focal versus diffuse coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources